0.020708
0.011956
0.000000
0.000000
0.023912
0.000000
0.000000
0.000000
0.025445
0.00000
0.00000
0.00000
Lehmann, C.
Bunkoczi, G.
Sheldrick, G.M.
Vertesy, L.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
18
90.00
90.00
120.00
48.290
48.290
39.300
C8 H9 N O4
183.161
(2S)-amino(3,5-dihydroxyphenyl)ethanoic acid
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C3 H7 N O2
89.093
D-ALANINE
D-peptide linking
C7 H15 N O4
177.198
(2R,4S,6S)-4-azanyl-4,6-dimethyl-oxane-2,5,5-triol
L-saccharide, alpha linking
C5 H9 N O4
147.129
GAMMA-D-GLUTAMIC ACID
D-GLUTAMIC ACID
D-gamma-peptide, C-delta linking
C8 H9 N O3
167.162
(2R)-amino(4-hydroxyphenyl)ethanoic acid
D-peptide linking
H2 O
18.015
WATER
non-polymer
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C7 H15 N O2
145.199
N-methyl-D-leucine
D-peptide linking
C9 H10 Cl N O4
231.633
n
(betaR)-3-chloro-beta-hydroxy-L-tyrosine
L-peptide linking
C9 H10 Cl N O4
231.633
(betaR)-3-CHLORO-BETA-HYDROXY-D-TYROSINE
D-peptide linking
C3 H8 O2
76.094
R-1,2-PROPANEDIOL
non-polymer
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
318
723
10.1016/S0022-2836(02)00146-8
12054818
Structures of Glycopeptide Antibiotics with Peptides that Model Bacterial Cell-Wall Precursors
2002
DAL E 1 HAS WRONG CHIRALITY AT ATOM CA
DAL E 1 C-ALPHA WRONG HAND DAL E 1 C-ALPHA WRONG HAND
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
100.0
1
IMAGE PLATE
1999-03-15
MARRESEARCH
SINGLE WAVELENGTH
M
x-ray
1
0.9114
1.0
X11
EMBL/DESY, HAMBURG
0.9114
SYNCHROTRON
EMBL/DESY, HAMBURG BEAMLINE X11
1149.977
DEGLUCOBALHIMYCIN
3
syn
polymer
489.542
CELL WALL PEPTIDE
3
syn
polymer
177.198
(2R,4S,6S)-4-azanyl-4,6-dimethyl-oxane-2,5,5-triol
3
man
non-polymer
76.094
R-1,2-PROPANEDIOL
4
syn
non-polymer
18.015
water
95
nat
water
no
yes
(MLU)(OMZ)N(GHP)(GHP)(OMY)(3FG)
XXNGGYX
A,B,C
polypeptide(L)
no
yes
(DAL)(FGA)K(DAL)(DAL)
AEKAA
D,E,F
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
1
2.7
38.1
7.00
0.3M CIT, PH=7, 30% 1,2-PROPANEDIOL, pH 7.00
chem_comp
diffrn_source
entity_poly
pdbx_database_proc
pdbx_database_status
pdbx_seq_map_depositor_info
pdbx_validate_polymer_linkage
struct_conn
diffrn_source
chem_comp
diffrn_source
pdbx_database_status
pdbx_entity_src_syn
chem_comp
database_PDB_caveat
struct_conn
struct_site
struct_site_gen
repository
Initial release
Carbohydrate remediation
repository
Remediation
Atomic model
Database references
Derived calculations
Structure summary
Version format compliance
Atomic model
Derived calculations
Non-polymer description
Other
Other
Advisory
Data collection
Derived calculations
Other
Polymer sequence
Data collection
Data collection
Data collection
Other
Source and taxonomy
Advisory
Data collection
Derived calculations
1
0
2003-09-05
1
1
2011-07-13
1
2
2012-07-25
1
3
2012-11-30
2
0
2019-04-24
2
1
2019-07-10
2
2
2019-07-24
2
3
2019-10-09
2
4
2020-07-29
_chem_comp.type
_diffrn_source.pdbx_synchrotron_site
_entity_poly.pdbx_seq_one_letter_code_can
_pdbx_database_status.recvd_author_approval
_pdbx_seq_map_depositor_info.one_letter_code
_struct_conn.pdbx_leaving_atom_flag
_diffrn_source.pdbx_synchrotron_site
_chem_comp.type
_diffrn_source.pdbx_synchrotron_site
_pdbx_database_status.status_code_sf
_chem_comp.type
_struct_conn.pdbx_dist_value
_struct_conn.pdbx_leaving_atom_flag
_struct_conn.ptnr1_label_atom_id
_struct_conn.ptnr2_auth_comp_id
_struct_conn.ptnr2_auth_seq_id
_struct_conn.ptnr2_label_asym_id
_struct_conn.ptnr2_label_atom_id
_struct_conn.ptnr2_label_comp_id
_struct_conn.ptnr2_label_seq_id
CRYSTAL STRUCTURE OF BALHIMYCIN COMPLEXED WITH THE PEPTIDE LYS-DAL-DAL
CRYSTAL STRUCURE OF DEGLUCOBALHIMYCIN COMPLEXED WITH DAL-DAL
CRYSTAL STRUCTURE OF BALHIMYCIN COMPLEXED WITH DAL-DAL
PDBE
Y
PDBE
2000-12-29
REL
REL
1
B
O
HOH
2004
6.01
DVC
(2R,4S,6S)-4-azanyl-4,6-dimethyl-oxane-2,5,5-triol
PGR
R-1,2-PROPANEDIOL
HOH
water
37632
AMYCOLATOPSIS SP.
sample
32630
synthetic construct
sample
BALHIMYCIN IS A TRICYCLIC GLYCOPEPTIDE. THE SCAFFOLD IS
A HEPTAPEPTIDE WITH THE CONFIGURATION D-D-L-D-D-L-L. IT IS
FURTHER GLYCOSYLATED BY TWO MONOSACCHARIDES: A D-GLUCOSE
AND A 4-OXO-VANCOSAMINE.
HERE, DEGLUCOBALHIMYCIN IS REPRESENTED GROUPING TOGETHER THE
SEQUENCE (SEQRES) AND ONE LIGAND (HET) DVC.
GROUP: 1
NAME: DEGLUCOBALHIMYCIN
CHAIN: A, B, C
COMPONENT_1: PEPTIDE LIKE SEQUENCE RESIDUES 1 TO 7
COMPONENT_2: SUGAR RESIDUES 9
DESCRIPTION: DEGLUCOBALHIMYCIN LACKS THE D-GLUCOSE
COMPONENT OF BALHIMYCIN CONSISTING OF THE
TRICYCLIC HEPTAPEPTIDE AND 4-OXO-VANCOSAMINE
ONLY, LINKED TO RESIDUE 6.
Antibiotic, Antimicrobial
DEGLUCOBALHIMYCIN LACKS THE D-GLUCOSE
COMPONENT OF BALHIMYCIN CONSISTING OF THE
TRICYCLIC HEPTAPEPTIDE AND (2R,4S,6S)-4-AZANYL-4,6-DIMETHYL-OXANE-2,5,5-TRIOL
ONLY LINKED TO RESIDUE 6.
Deglucobalhimycin
Glycopeptide
DVC
9
3
DVC
DVC
9
A
PGR
1001
4
PGR
PGR
1001
A
PGR
1002
4
PGR
PGR
1002
A
DVC
9
3
DVC
DVC
9
B
PGR
1001
4
PGR
PGR
1001
B
DVC
9
3
DVC
DVC
9
C
PGR
1001
4
PGR
PGR
1001
C
HOH
2001
5
HOH
HOH
2001
A
HOH
2002
5
HOH
HOH
2002
A
HOH
2003
5
HOH
HOH
2003
A
HOH
2004
5
HOH
HOH
2004
A
HOH
2005
5
HOH
HOH
2005
A
HOH
2006
5
HOH
HOH
2006
A
HOH
2007
5
HOH
HOH
2007
A
HOH
2008
5
HOH
HOH
2008
A
HOH
2009
5
HOH
HOH
2009
A
HOH
2010
5
HOH
HOH
2010
A
HOH
2011
5
HOH
HOH
2011
A
HOH
2012
5
HOH
HOH
2012
A
HOH
2013
5
HOH
HOH
2013
A
HOH
2014
5
HOH
HOH
2014
A
HOH
2015
5
HOH
HOH
2015
A
HOH
2016
5
HOH
HOH
2016
A
HOH
2017
5
HOH
HOH
2017
A
HOH
2018
5
HOH
HOH
2018
A
HOH
2019
5
HOH
HOH
2019
A
HOH
2020
5
HOH
HOH
2020
A
HOH
2021
5
HOH
HOH
2021
A
HOH
2022
5
HOH
HOH
2022
A
HOH
2023
5
HOH
HOH
2023
A
HOH
2024
5
HOH
HOH
2024
A
HOH
2025
5
HOH
HOH
2025
A
HOH
2001
5
HOH
HOH
2001
B
HOH
2002
5
HOH
HOH
2002
B
HOH
2003
5
HOH
HOH
2003
B
HOH
2004
5
HOH
HOH
2004
B
HOH
2005
5
HOH
HOH
2005
B
HOH
2006
5
HOH
HOH
2006
B
HOH
2007
5
HOH
HOH
2007
B
HOH
2008
5
HOH
HOH
2008
B
HOH
2009
5
HOH
HOH
2009
B
HOH
2010
5
HOH
HOH
2010
B
HOH
2011
5
HOH
HOH
2011
B
HOH
2012
5
HOH
HOH
2012
B
HOH
2013
5
HOH
HOH
2013
B
HOH
2014
5
HOH
HOH
2014
B
HOH
2015
5
HOH
HOH
2015
B
HOH
2016
5
HOH
HOH
2016
B
HOH
2017
5
HOH
HOH
2017
B
HOH
2018
5
HOH
HOH
2018
B
HOH
2019
5
HOH
HOH
2019
B
HOH
2020
5
HOH
HOH
2020
B
HOH
2021
5
HOH
HOH
2021
B
HOH
2022
5
HOH
HOH
2022
B
HOH
2023
5
HOH
HOH
2023
B
HOH
2024
5
HOH
HOH
2024
B
HOH
2025
5
HOH
HOH
2025
B
HOH
2026
5
HOH
HOH
2026
B
HOH
2027
5
HOH
HOH
2027
B
HOH
2028
5
HOH
HOH
2028
B
HOH
2029
5
HOH
HOH
2029
B
HOH
2001
5
HOH
HOH
2001
C
HOH
2002
5
HOH
HOH
2002
C
HOH
2003
5
HOH
HOH
2003
C
HOH
2004
5
HOH
HOH
2004
C
HOH
2005
5
HOH
HOH
2005
C
HOH
2006
5
HOH
HOH
2006
C
HOH
2007
5
HOH
HOH
2007
C
HOH
2008
5
HOH
HOH
2008
C
HOH
2009
5
HOH
HOH
2009
C
HOH
2010
5
HOH
HOH
2010
C
HOH
2011
5
HOH
HOH
2011
C
HOH
2012
5
HOH
HOH
2012
C
HOH
2013
5
HOH
HOH
2013
C
HOH
2014
5
HOH
HOH
2014
C
HOH
2015
5
HOH
HOH
2015
C
HOH
2016
5
HOH
HOH
2016
C
HOH
2017
5
HOH
HOH
2017
C
HOH
2018
5
HOH
HOH
2018
C
HOH
2001
5
HOH
HOH
2001
D
HOH
2002
5
HOH
HOH
2002
D
HOH
2003
5
HOH
HOH
2003
D
HOH
2004
5
HOH
HOH
2004
D
HOH
2005
5
HOH
HOH
2005
D
HOH
2006
5
HOH
HOH
2006
D
HOH
2007
5
HOH
HOH
2007
D
HOH
2008
5
HOH
HOH
2008
D
HOH
2001
5
HOH
HOH
2001
E
HOH
2002
5
HOH
HOH
2002
E
HOH
2003
5
HOH
HOH
2003
E
HOH
2004
5
HOH
HOH
2004
E
HOH
2005
5
HOH
HOH
2005
E
HOH
2006
5
HOH
HOH
2006
E
HOH
2007
5
HOH
HOH
2007
E
HOH
2008
5
HOH
HOH
2008
E
HOH
2009
5
HOH
HOH
2009
E
HOH
2010
5
HOH
HOH
2010
E
HOH
2011
5
HOH
HOH
2011
E
HOH
2001
5
HOH
HOH
2001
F
HOH
2002
5
HOH
HOH
2002
F
HOH
2003
5
HOH
HOH
2003
F
HOH
2004
5
HOH
HOH
2004
F
MLU
1
n
1
MLU
1
A
OMZ
2
n
2
OMZ
2
A
ASN
3
n
3
ASN
3
A
GHP
4
n
4
GHP
4
A
GHP
5
n
5
GHP
5
A
OMY
6
n
6
OMY
6
A
3FG
7
n
7
3FG
7
A
MLU
1
n
1
MLU
1
B
OMZ
2
n
2
OMZ
2
B
ASN
3
n
3
ASN
3
B
GHP
4
n
4
GHP
4
B
GHP
5
n
5
GHP
5
B
OMY
6
n
6
OMY
6
B
3FG
7
n
7
3FG
7
B
MLU
1
n
1
MLU
1
C
OMZ
2
n
2
OMZ
2
C
ASN
3
n
3
ASN
3
C
GHP
4
n
4
GHP
4
C
GHP
5
n
5
GHP
5
C
OMY
6
n
6
OMY
6
C
3FG
7
n
7
3FG
7
C
n
1
1
D
FGA
2
n
2
FGA
2
D
LYS
3
n
3
LYS
3
D
DAL
4
n
4
DAL
4
D
DAL
5
n
5
DAL
5
D
DAL
1
n
1
DAL
1
E
FGA
2
n
2
FGA
2
E
LYS
3
n
3
LYS
3
E
DAL
4
n
4
DAL
4
E
DAL
5
n
5
DAL
5
E
n
1
1
F
FGA
2
n
2
FGA
2
F
LYS
3
n
3
LYS
3
F
DAL
4
n
4
DAL
4
F
DAL
5
n
5
DAL
5
F
0.1031
0.1083
0.1022
0.1075
0.1354
0.1403
1413
1529
5.2
5.1
27252
software_defined_assembly
PISA
4
tetrameric
software_defined_assembly
PISA
4
tetrameric
1390
-6.4
3270
2240
-15.8
2280
A
OMY
6
A
OMY
6
TYR
B
OMY
6
B
OMY
6
TYR
C
OMY
6
C
OMY
6
TYR
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
-1.0000000000
0.0000000000
0.0000000000
0.0000000000
-1.0000000000
5_556
x-y,-y,-z+4/3
crystal symmetry operation
0.0000000000
0.0000000000
52.4000000000
A
N
GHP
4
A
N
GHP
4
D
O
DAL
5
D
O
DAL
5
B
N
GHP
4
B
N
GHP
4
E
O
DAL
5
E
O
DAL
5
1
A
HOH
2006
N
HOH
1
F
HOH
2001
S
HOH
1
D
N
FGA
2
D
N
FGA
2
1
Y
1
D
CA
FGA
2
D
CA
FGA
2
1
Y
1
D
C
FGA
2
D
C
FGA
2
1
Y
1
D
O
FGA
2
D
O
FGA
2
1
Y
1
D
CB
FGA
2
D
CB
FGA
2
1
Y
1
D
CD
LYS
3
D
CD
LYS
3
1
Y
1
D
CE
LYS
3
D
CE
LYS
3
1
Y
1
D
NZ
LYS
3
D
NZ
LYS
3
1
Y
1
F
C
FGA
2
F
C
FGA
2
1
Y
1
F
O
FGA
2
F
O
FGA
2
1
Y
1
D
DAL
1
D
DAL
1
1
Y
1
F
DAL
1
F
DAL
1
1
Y
1
E
CA
DAL
1
WRONG HAND
A
1
E
CA
DAL
1
WRONG HAND
B
1
A
ASN
3
-120.78
-56.01
0.1403
0.1083
0.1075
0.99
41.85
4237
1529
29932
4905
5.1
99.9
SHELLS
1
THROUGHOUT
DIRECT METHODS
ENGH AND HUBER
METHOD USED: MOEWS & KRETSINGER, J.MOL.BIOL.91(1973)201-228
6
280.80
448.50
0.99
41.85
95
468
53
0
320
0.021
0.032
0.027
0.086
0.084
0.190
0.085
0.005
0.027
0.126
0.990
41.850
1HHZ
29932
0.05300
1
7.500
99.9
0.19000
0.99
1.10
1
7.50
100.0
refinement
SHELXL-97
data reduction
DENZO
data scaling
SCALEPACK
phasing
SHELX
DEGLUCOBALHIMYCIN, CELL WALL PEPTIDE
Deglucobalhimycin in complex with cell wall pentapeptide
1
N
N
1
N
N
1
N
N
2
N
N
2
N
N
2
N
N
3
N
N
4
N
N
4
N
N
3
N
N
4
N
N
3
N
N
4
N
N
5
N
N
5
N
N
5
N
N
5
N
N
5
N
N
5
N
N
covale
1.354
both
A
MLU
1
A
C
MLU
1
1_555
A
OMZ
2
A
N
OMZ
2
1_555
covale
1.322
both
A
OMZ
2
A
C
OMZ
2
1_555
A
ASN
3
A
N
ASN
3
1_555
covale
1.387
none
A
OMZ
2
A
OH
OMZ
2
1_555
A
GHP
4
A
C3
GHP
4
1_555
covale
1.338
both
A
ASN
3
A
C
ASN
3
1_555
A
GHP
4
A
N
GHP
4
1_555
covale
1.340
both
A
GHP
4
A
C
GHP
4
1_555
A
GHP
5
A
N
GHP
5
1_555
covale
1.387
none
A
GHP
4
A
C5
GHP
4
1_555
A
OMY
6
A
OCZ
OMY
6
1_555
covale
1.346
both
A
GHP
5
A
C
GHP
5
1_555
A
OMY
6
A
N
OMY
6
1_555
covale
1.489
none
A
GHP
5
A
C5
GHP
5
1_555
A
3FG
7
A
CG1
3FG
7
1_555
covale
1.351
both
A
OMY
6
A
C
OMY
6
1_555
A
3FG
7
A
N
3FG
7
1_555
covale
1.424
one
A
OMY
6
A
ODE
OMY
6
1_555
A
DVC
9
G
C1
DVC
1_555
covale
1.375
both
B
MLU
1
B
C
MLU
1
1_555
B
OMZ
2
B
N
OMZ
2
1_555
covale
1.304
both
B
OMZ
2
B
C
OMZ
2
1_555
B
ASN
3
B
N
ASN
3
1_555
covale
1.391
none
B
OMZ
2
B
OH
OMZ
2
1_555
B
GHP
4
B
C3
GHP
4
1_555
covale
1.347
both
B
ASN
3
B
C
ASN
3
1_555
B
GHP
4
B
N
GHP
4
1_555
covale
1.344
both
B
GHP
4
B
C
GHP
4
1_555
B
GHP
5
B
N
GHP
5
1_555
covale
1.399
none
B
GHP
4
B
C5
GHP
4
1_555
B
OMY
6
B
OCZ
OMY
6
1_555
covale
1.317
both
B
GHP
5
B
C
GHP
5
1_555
B
OMY
6
B
N
OMY
6
1_555
covale
1.486
none
B
GHP
5
B
C5
GHP
5
1_555
B
3FG
7
B
CG1
3FG
7
1_555
covale
1.314
both
B
OMY
6
B
C
OMY
6
1_555
B
3FG
7
B
N
3FG
7
1_555
covale
1.419
one
B
OMY
6
B
ODE
OMY
6
1_555
B
DVC
9
J
C1
DVC
1_555
covale
1.382
both
C
MLU
1
C
C
MLU
1
1_555
C
OMZ
2
C
N
OMZ
2
1_555
covale
1.311
both
C
OMZ
2
C
C
OMZ
2
1_555
C
ASN
3
C
N
ASN
3
1_555
covale
1.408
none
C
OMZ
2
C
OH
OMZ
2
1_555
C
GHP
4
C
C3
GHP
4
1_555
covale
1.337
both
C
ASN
3
C
C
ASN
3
1_555
C
GHP
4
C
N
GHP
4
1_555
covale
1.332
both
C
GHP
4
C
C
GHP
4
1_555
C
GHP
5
C
N
GHP
5
1_555
covale
1.393
none
C
GHP
4
C
C5
GHP
4
1_555
C
OMY
6
C
OCZ
OMY
6
1_555
covale
1.325
both
C
GHP
5
C
C
GHP
5
1_555
C
OMY
6
C
N
OMY
6
1_555
covale
1.498
none
C
GHP
5
C
C5
GHP
5
1_555
C
3FG
7
C
CG1
3FG
7
1_555
covale
1.332
both
C
OMY
6
C
C
OMY
6
1_555
C
3FG
7
C
N
3FG
7
1_555
covale
1.392
one
C
OMY
6
C
ODE
OMY
6
1_555
C
DVC
9
L
C1
DVC
1_555
covale
1.448
both
D
FGA
2
D
CD
FGA
2
1_555
D
LYS
3
D
N
LYS
3
1_555
covale
1.311
both
D
LYS
3
D
C
LYS
3
1_555
D
DAL
4
D
N
DAL
4
1_555
covale
1.302
both
D
DAL
4
D
C
DAL
4
1_555
D
DAL
5
D
N
DAL
5
1_555
covale
1.451
both
B
E
DAL
1
E
C
DAL
1
1_555
E
FGA
2
E
N
FGA
2
1_555
covale
1.362
both
A
E
DAL
1
E
C
DAL
1
1_555
E
FGA
2
E
N
FGA
2
1_555
covale
1.326
both
E
FGA
2
E
CD
FGA
2
1_555
E
LYS
3
E
N
LYS
3
1_555
covale
1.322
both
E
LYS
3
E
C
LYS
3
1_555
E
DAL
4
E
N
DAL
4
1_555
covale
1.326
both
E
DAL
4
E
C
DAL
4
1_555
E
DAL
5
E
N
DAL
5
1_555
covale
1.415
both
F
FGA
2
F
CD
FGA
2
1_555
F
LYS
3
F
N
LYS
3
1_555
covale
1.331
both
F
LYS
3
F
C
LYS
3
1_555
F
DAL
4
F
N
DAL
4
1_555
covale
1.338
both
F
DAL
4
F
C
DAL
4
1_555
F
DAL
5
F
N
DAL
5
1_555
ANTIBIOTIC/PEPTIDE
ANTIBIOTIC-PEPTIDE COMPLEX, GLYCOPEPTIDE, ANTIBIOTIC, CELL WALL PEPTIDE, BALHIMYCIN
A
GHP
5
A
GHP
5
1
A
OMY
6
A
OMY
6
10.12
B
GHP
5
B
GHP
5
1
B
OMY
6
B
OMY
6
-0.30
C
GHP
5
C
GHP
5
1
C
OMY
6
C
OMY
6
5.84
given
-0.818060
-0.282480
-0.500970
0.274980
0.572940
-0.772090
0.505130
-0.769380
-0.391030
69.43897
18.29514
12.76565
given
-0.784650
0.257220
0.564060
0.349730
-0.567600
0.745340
0.511870
0.782100
0.355410
40.43910
-24.31767
-7.14059
NOR00707
NOR
1
NOR00707
1HHZ
PDB
2
1HHZ
1
7
1HHZ
1
7
NOR00707
A
1
1
7
1
7
1HHZ
1
7
NOR00707
B
1
1
7
1
7
1HHZ
1
7
NOR00707
C
1
1
7
1
5
1HHZ
1
5
1HHZ
D
2
1
5
1
5
1HHZ
1
5
1HHZ
E
2
1
5
1
5
1HHZ
1
5
1HHZ
F
2
1
5
2
2
anti-parallel
anti-parallel
A
GHP
4
A
GHP
4
A
GHP
5
A
GHP
5
D
DAL
4
D
DAL
4
D
DAL
5
D
DAL
5
B
GHP
4
B
GHP
4
B
GHP
5
B
GHP
5
E
DAL
4
E
DAL
4
E
DAL
5
E
DAL
5
154
P 32 2 1